The global ENT devices market was valued at $5.7 billion in 2008. Driven by growth in the hearing implants category, the market is forecast to grow by 8% annually during 2008-2015 to reach $10 billion by 2015. However, the hearing aid devices category will continue to be the major contributor to the overall market value.
As this sector continues to grapple with the challenges posed by reduced consumer discretionary spending, the competitive landscape is not expected to see significant dynamism. One of the least fragmented medical equipment markets, the global ENT Devices market is dominated William Demant, Sonova, GN ReSound, Siemens Healthcare, Widex and Starkey Laboratories which together accounted for more than two-third of the market in 2007.
|
|
This latest ENT devices market data and analysis was taken from the research report
"Global ENT Devices Investment Opportunities, Analysis and Forecasts to 2015" published by Global Markets Direct - for more information on this report,
Click Here
|
|
* Indicates Mandatory
|